GlassScriptPhysician profile
Luiz De Souza
NPI 1467847533
$1,741.21
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,355 · 2020: $133 · 2021: $252.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,147.93 | 2019-2020 | |
| Abbott Laboratories | $220.19 | 2019 | |
| Amgen INC. | $76.63 | 2020-2021 | |
| Allergan, INC. | $64.16 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $55.03 | 2020-2021 | |
| Lilly USA, LLC | $50.47 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $23.08 | 2021 | |
| Abbvie INC. | $19.37 | 2021 | |
| Almatica Pharma LLC | $19.27 | 2021 | |
| Fidia Pharma USA INC. | $18.53 | 2021 | |
| Biodelivery Sciences International, INC. | $18.22 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.92 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.41 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luiz De Souza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.